Alkem PAT down at ₹675 crore; biotech sales down 37% on ‘lumpy’ CDMO business

The Hindu Business Line - Nov 13, 2026

The company posted total revenue from operations at ₹4,552 crore, up 13.8% compared to the same period last year

Read full article
More News
Copyright © 2015 - 2026 The Financial Capital.

All Rights Reserved.

Subscribe Now!

About Us

The Financial Capital is your independent source for finance information and advice. We provide insights and offer advice from financial experts so you can make the best decisions.